Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
JAK Inhibitors
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
Pt had chest tightness and tinging that resolved with diphenhydramine.
Related Questions
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
What is your approach to differentiating and managing DMARD-induced nodulosis (induced by methotrexate or leflunomide for example) from "de novo" RA nodules in seropositive RA patients?
What is your approach to using topical JAK inhibitors in the management of cutaneous manifestations of rheumatic disease?
What is the maximum dose of leucovorin that you use with methotrexate?
Do you combine methotrexate and leflunomide for the treatment of RA?
What is your approach to work up for patients referred for early onset osteoarthritis?
How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Would you prescribe a JAK inhibitor in patients with baseline transaminase elevation?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?